Literature DB >> 24521289

Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies.

Scott Miners1, Hayley Moulding, Rohan de Silva, Seth Love.   

Abstract

In dementia with Lewy bodies (DLB), blood flow tends to be reduced in the occipital cortex. We previously showed elevated activity of the endothelin and angiotensin pathways in Alzheimer's disease (AD). We have measured endothelin-1 (ET-1) level and angiotensin-converting enzyme (ACE) activity in the occipital cortex in DLB and control brains. We also measured vascular endothelial growth factor (VEGF); factor VIII-related antigen (FVIIIRA) to indicate microvessel density; myelin-associated glycoprotein (MAG), a marker of ante-mortem hypoperfusion; total α-synuclein (α-syn) and α-synuclein phosphorylated at Ser129 (α-syn-p129). In contrast to findings in AD, ACE activity and ET-1 level were unchanged in DLB compared with controls. VEGF and FVIIIRA levels were, however, significantly lower in DLB. VEGF correlated positively with MAG concentration (in keeping with a relationship between reduction in VEGF and hypoperfusion), and negatively with α-syn and α-syn-p129 levels. Both α-syn and α-syn-p129 levels increased in human SH-SY5Y neuroblastoma cells after oxygen-glucose deprivation (OGD), and VEGF level was reduced in SH-SY5Y cells overexpressing α-syn. Taken together, our findings suggest that reduced microvessel density rather than vasoconstriction is responsible for lower occipital blood flow in DLB, and that the loss of microvessels may result from VEGF deficiency, possible secondary to the accumulation of α-syn.
© 2014 International Society of Neuropathology.

Entities:  

Keywords:  VEGF; dementia with Lewy bodies; factor VIII-related antigen; hypoperfusion; oxygen-gluocose deprivation

Mesh:

Substances:

Year:  2014        PMID: 24521289     DOI: 10.1111/bpa.12130

Source DB:  PubMed          Journal:  Brain Pathol        ISSN: 1015-6305            Impact factor:   6.508


  18 in total

Review 1.  The neuropathology and cerebrovascular mechanisms of dementia.

Authors:  Limor Raz; Janice Knoefel; Kiran Bhaskar
Journal:  J Cereb Blood Flow Metab       Date:  2016-01       Impact factor: 6.200

2.  Cerebral regional and network characteristics in asthma patients: a resting-state fMRI study.

Authors:  Siyi Li; Peilin Lv; Min He; Wenjing Zhang; Jieke Liu; Yao Gong; Ting Wang; Qiyong Gong; Yulin Ji; Su Lui
Journal:  Front Med       Date:  2020-04-08       Impact factor: 4.592

Review 3.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease.

Authors:  Costantino Iadecola
Journal:  Neuron       Date:  2017-09-27       Impact factor: 17.173

Review 4.  Connexins in Cardiovascular and Neurovascular Health and Disease: Pharmacological Implications.

Authors:  Luc Leybaert; Paul D Lampe; Stefan Dhein; Brenda R Kwak; Peter Ferdinandy; Eric C Beyer; Dale W Laird; Christian C Naus; Colin R Green; Rainer Schulz
Journal:  Pharmacol Rev       Date:  2017-10       Impact factor: 25.468

Review 5.  Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.

Authors:  Veronica Galvan; Matthew J Hart
Journal:  Biochim Biophys Acta       Date:  2015-11-27

6.  White matter hypoperfusion and damage in dementia: post-mortem assessment.

Authors:  Seth Love; J Scott Miners
Journal:  Brain Pathol       Date:  2015-01       Impact factor: 6.508

7.  Synaptic protein levels altered in vascular dementia.

Authors:  Lindsey I Sinclair; Hannah M Tayler; Seth Love
Journal:  Neuropathol Appl Neurobiol       Date:  2015-04-23       Impact factor: 8.090

8.  Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease.

Authors:  Marta Swirski; J Scott Miners; Rohan de Silva; Tammaryn Lashley; Helen Ling; Janice Holton; Tamas Revesz; Seth Love
Journal:  Alzheimers Res Ther       Date:  2014-12-01       Impact factor: 6.982

9.  Accumulation of α-synuclein in dementia with Lewy bodies is associated with decline in the α-synuclein-degrading enzymes kallikrein-6 and calpain-1.

Authors:  J Scott Miners; Ruth Renfrew; Marta Swirski; Seth Love
Journal:  Acta Neuropathol Commun       Date:  2014-12-05       Impact factor: 7.801

Review 10.  Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes.

Authors:  J Scott Miners; Jennifer C Palmer; Hannah Tayler; Laura E Palmer; Emma Ashby; Patrick G Kehoe; Seth Love
Journal:  Front Aging Neurosci       Date:  2014-09-11       Impact factor: 5.750

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.